<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en" dir="ltr">
<head>
<meta http-equiv="Content-Type" content="text/html; charset=euc-jp" />
<meta http-equiv="content-style-type" content="text/css" />
<meta http-equiv="content-script-type" content="text/javascript" />

<title>Past Issues | YAKUGAI Ombudsperson &quot;Medwatcher Japan&quot;</title>

<meta name="Description" content="YAKUGAI Ombudsperson &quot;Medwatcher Japan&quot;" />
<meta name="Keywords" content="YAKUGAI Ombudsperson &quot;Medwatcher Japan&quot;" />
<meta http-equiv="imagetoolbar" content="no" />
<link rel="stylesheet" type="text/css" media="all" href="../../css/style.css" />
<link rel="stylesheet" type="text/css" media="all" href="../../css/en.css" />
<script type="text/javascript" src="../../js/jquery.js"></script>
<script type="text/javascript" src="../../js/jquery.function.js"></script>
</head>

<body class="page">
<div id="container">

<div id="header">
<p id="siteLogo"><a href="../../en.html"><img src="../../img/common/logo_en.gif" alt="YAKUGAI Ombudsperson &quot;Medwatcher Japan&quot;" width="437" height="28" /></a></p>
<p id="tagline"> YAKUGAI Ombudsperson &quot;Medwatcher Japan&quot; is the private medical supply supervisory system.</p>
<div id="navUtility">
<ul>
<li><a href="../sitemap.html">Sitemap</a></li>
<li><a href="../../index.html">Japanese</a></li>
</ul>
<!-- /#navUtility --></div>
<div id="searchArea">
<form name="form1" action="http://www.yakugai.gr.jp/en/search.php" method="post">
<p><input id="searchInput" name="keyword" type="text" />&nbsp;<input value="Search" type="submit" /></p>
</form>
<!-- /#searchInput --></div>
<!-- /#header --></div>

<div id="nav">
<ul>
<li id="navHome"><a href="../../en.html">Home</a></li>
<li><a href="../about.html">About Us</a></li>
<li><a href="../activity.html">Activities</a></li>
<li class="current"><a href="../inve.html">Past Issues</a></li>
<li><a href="../about/about_links.html">Links</a></li>
</ul>
<!-- /#nav --></div>

<div class="inve" id="pageTitle">
<h1>Past Issues</h1>
<!-- /#pageTitle --></div>

<div id="topicPath">
<ol>
<li id="topicPathHome"><a href="../../en.html">Home</a></li>
<li>Past Issues</li>
</ol>
<!-- /#topicPath --></div>

<div id="contents">

<div id="main">

<h2 id="inveDrug">We have addressed the following drug issues</h2>
<ul>
<li><a href="fileview.php@id=25.html">Actos (pioglitazone hydrochloride)</a></li>
<li><a href="fileview.php@id=80.html">Adoair Diskus（fulticasone propionate/salmeterol xinafoate dry-powder inhaler）</a></li>
<li><a href="fileview.php@id=32.html">Albumin (human serum albumin)</a></li>
<li><a href="fileview.php@id=66.html">Arava (leflunomide)</a></li>
<li><a href="fileview.php@id=31.html">Berotec Aerosol (fenoterol hydrobromide)</a></li>
<li><a href="fileview.php@id=46.html">BSE</a></li>
<li><a href="fileview.php@id=30.html">Cerebral Metabolic Enhancers</a></li>
<li><a href="fileview.php@id=84.html">Champix (varenicline tartrate)</a></li>
<li><a href="fileview.php@id=52.html">cholesterol reducers,antihyperlipemics</a></li>
<li>Dormicum (midazolam)</li>
<li><a href="fileview.php@id=79.html">Drug Eluting Stent (DES)</a></li>
<li><a href="fileview.php@id=83.html">Enbrel (Etanercept)</a></li>
<li><a href="fileview.php@id=85.html">EVAHEART</a></li>
<li><a href="fileview.php@id=61.html">Fluoride Mouth Rinsing Program </a></li>
<li><a href="fileview.php@id=76.html">Gatiflo (gatifloxacin hydrate)</a></li>
<li><a href="fileview.php@id=24.html">H2-receptor antagonist</a></li>
<li><a href="fileview.php@id=49.html">Halcion (triazolam)</a></li>
<li><a href="fileview.php@id=33.html">Idamycin (idarubicin hydrochloride)</a></li>
<li><a href="fileview.php@id=48.html">Influenza HA Vaccine</a></li>
<li><a href="fileview.php@id=58.html">Iressa (Gefitinib)</a></li>
<li><a href="fileview.php@id=27.html">Mylis (sodium prasterone sulfate)</a></li>
<li>Noscal (troglitazone)</li>
<li><a href="fileview.php@id=51.html">Panaldine (ticlopidine hydrochloride) </a></li>
<li>pharmaceutical additives, especially butylated hydroxyanisole (BHA) and butylated hydroxytoluene (BHT)</li>
<li><a href="fileview.php@id=39.html">PPA: phenylpropanolamine hydrochloride</a></li>
<li><a href="fileview.php@id=59.html">Protopic Ointment (tacrolimus hydrate)</a></li>
<li><a href="fileview.php@id=60.html">Radicut (edaravone)</a></li>
<li><a href="fileview.php@id=28.html">Seirogan (wood creosote)</a></li>
<li><a href="fileview.php@id=67.html">SSRI - Paxil etc)</a></li>
<li><a href="fileview.php@id=75.html">Tamiflu (oseltamivir phosphate)</a></li>
<li><a href="fileview.php@id=41.html">Tap water Fluoridation</a></li>
<li><a href="fileview.php@id=47.html">Thalidomide</a></li>
<li><a href="fileview.php@id=29.html">Triludan (terfenadine)</a></li>
<li><a href="fileview.php@id=50.html">Zithromac (azithromycin hydrate)</a></li>
</ul>

<h2 id="inveSystem">We have addressed the following regulatory system issues</h2>
<ul>
<li><a href="fileview.php@id=89.html">Act on Protection of Patients Subject to Clinical Tests</a></li>
<li><a href="fileview.php@id=42.html">Advertisement of Recruiting Examinees</a></li>
<li><a href="fileview.php@id=87.html">Clinical Trials Registration System</a></li>
<li><a href="fileview.php@id=78.html">Conflict of interests</a></li>
<li><a href="fileview.php@id=55.html">Disclosure of  the Reports of  Side Effects of Seirogan (creosote)</a></li>
<li><a href="fileview.php@id=45.html">Educational Video Produced by the JPMA </a></li>
<li><a href="fileview.php@id=43.html">Freedom-of-information requests regarding the minutes of pharmaceutical committees at hospitals</a></li>
<li><a href="fileview.php@id=37.html">Guidelines on Interaction</a></li>
<li><a href="fileview.php@id=57.html">New Drug Application (NDA) system that accepted only published data in applications for drug licensing</a></li>
<li><a href="fileview.php@id=74.html">PPA:phenylpropanolamine hydrochloride</a></li>
<li><a href="fileview.php@id=72.html">Regulation on OTC Drugs Online Selling</a></li>
<li><a href="fileview.php@id=96.html">Regulation Restricting Employment from Pharmaceutical Industries of the Employment in PMDA </a></li>
<li><a href="fileview.php@id=88.html">Revision of Guidelines on the Clinical Evaluation Method of Anti-malignant Tumor Medicine</a></li>
<li><a href="fileview.php@id=62.html">The PMDA (Pharmaceuticals and Medical Devices Agency) Act</a></li>
<li><a href="fileview.php@id=97.html">The Public Comment System </a></li>
</ul>

<!-- /#main --></div>

<div id="sub">
<h2>Table Of Contents</h2>
<div id="navSub">
<ul>
<li><a href="../inve.html#inveDrug">Drugs</a></li>
<li><a href="../inve.html#inveSystem">Systems</a></li>
</ul>
<!-- /#navSub --></div>
<!-- /#sub -->
</div>
<!-- /#contents --></div>

<div id="footer">
<p id="siteAdress">YAKUGAI Ombudsperson &quot;Medwatcher Japan&quot; Tie-up group<br />
160-0022　Tokyo Shinjuku Ward Shinjuku 1-14-4  AM building<br />
TEL : 03（3350）0607　FAX : 03（5363）7080<br />
Mail : <a href="mailto:info@yakugai.gr.jp">&#105;&#110;&#102;o&#64;y&#97;&#107;u&#103;&#97;&#105;&#46;&#103;r.&#106;&#112;</a></p>

<div id="footerInner">
<ul id="navFooter">
<li><a href="../privacy.html">Privacy Policy</a></li>
</ul>
<p id="siteInfo">Our members have other regular jobs and volunteer their services free of charge. Our secretariat also serves as part-time basis, and we are currently in the process of facilitating the secretariat function. Therefore, please note that due to limited resources, we might not be able to respond to each inquiry on specific medicine. Thank you for your understanding.</p>
<p id="copyright"><img src="../../img/common/copyright.gif" alt="Copyright (c) YAKUGAI Ombudsperson &quot;Medwatcher Japan&quot;. all rights reserved." width="419" height="11" /></p>
<!-- /#footerInner --></div>

<!-- /#footer --></div>

<!-- /#container --></div>

<!-- google Analytics -->
<script type="text/javascript">
var gaJsHost = (("https:" == document.location.protocol) ? "https://ssl." : "http://www.");
document.write(unescape("%3Cscript src='" + gaJsHost + "google-analytics.com/ga.js' type='text/javascript'%3E%3C/script%3E"));
</script>
<script type="text/javascript">
try {
var pageTracker = _gat._getTracker("UA-11615542-1");
pageTracker._trackPageview();
} catch(err) {}
</script>
<!-- /google Analytics -->
<!-- nakanohito -->
<script LANGUAGE="Javascript">
<!--
var refer = document.referrer;
document.write("<a href='http://nakanohito.jp/'>");
document.write("<img src='http://nakanohito.jp/an/?u=202528&h=897479&w=48&guid=ON&t=&version=js&refer="+escape(parent.document.referrer)+"&url="+escape(parent.document.URL)+"' border='0' width='48' height='48' />");
document.write("</a>");
//-->
</script>
<noscript>
<img src="http://nakanohito.jp/an/?u=202528&h=897479&w=48&guid=ON&t=" width="48" height="48" alt="" border="0" />
</noscript>
<!-- nakanohito end -->

</body>
</html>